Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Bone. 2018 Jan;106:1-10. doi: 10.1016/j.bone.2017.09.021. Epub 2017 Oct 1.
The purpose of this study is to investigate the effects of a single or combination therapy of teriparatide (TPTD) and anti-RANKL Ab (anti-murine receptor activator of nuclear factor κB ligand monoclonal antibody) on the regeneration of both cancellous and cortical bone.
Nine-week-old mice underwent bone defect surgery on the left femoral metaphysis (cancellous-bone healing model) and right femoral mid-diaphysis (cortical-bone healing model). After surgery, the mice were assigned to 1 of 4 groups to receive 1) saline (5 times a week; CNT group), 2) TPTD (40μg/kg 5 times a week; TPTD group), 3) anti-RANKL Ab (5mg/kg once; Ab group), or 4) a combination of TPTD and anti-RANKL Ab (COMB group). The following analyses were performed: Time-course microstructural analysis of healing in both cancellous and cortical bone in the bone defect, the volumetric bone mineral density of the tibia with micro-computed tomography, histological, histomorphometrical, and biomechanical analysis of regenerated bone.
Regeneration of cancellous bone volume in the COMB group was the highest among the 4 groups, and this combined administration prompted medullary callus formation in the early phase of bone regeneration. On the other hand, regeneration of cortical bone volume in the COMB group was significantly higher than in the Ab group and was almost same as in the TPTD group. Histological analysis showed remaining woven bones, cartilage matrix, and immature lamellar bone in the COMB and Ab groups. However, biomechanical analysis showed that hardness and Young's modulus of regenerated cortical bone in the COMB group was not lower than in both the CNT and TPTD groups. Volumetric bone mineral density in the tibia was significantly increased in the COMB group compared with the other 3 groups.
In the early phase of bone regeneration, the combination of TPTD and anti-RANKL Ab accelerates regeneration of cancellous bone in bone defects and increases cancellous bone mass in the tibia more effectively than either agent does individually, but these additive effects are not observed in the regeneration of cortical bone.
本研究旨在探讨特立帕肽(TPTD)单药治疗和抗 RANKL Ab(抗鼠核因子κB 配体受体激活剂单克隆抗体)联合治疗对松质骨和皮质骨再生的影响。
9 周龄小鼠在左侧股骨干骺端(松质骨愈合模型)和右侧股骨中段(皮质骨愈合模型)行骨缺损手术。手术后,将小鼠分为 4 组中的 1 组:1)生理盐水(每周 5 次;CNT 组)、2)TPTD(每周 5 次,40μg/kg;TPTD 组)、3)抗 RANKL Ab(单次,5mg/kg;Ab 组)或 4)TPTD 和抗 RANKL Ab 联合(COMB 组)。进行以下分析:骨缺损处松质骨和皮质骨愈合的时程微观结构分析、胫骨体积骨密度的微计算机断层扫描、再生骨的组织学、组织形态计量学和生物力学分析。
COMB 组的松质骨体积再生最高,这种联合给药在骨再生的早期促进髓腔骨痂形成。另一方面,COMB 组的皮质骨体积再生明显高于 Ab 组,几乎与 TPTD 组相同。组织学分析显示 COMB 和 Ab 组存在残留编织骨、软骨基质和不成熟的板层骨。然而,生物力学分析显示 COMB 组再生皮质骨的硬度和杨氏模量不低于 CNT 和 TPTD 组。与其他 3 组相比,COMB 组胫骨的体积骨密度显著增加。
在骨再生的早期阶段,TPTD 和抗 RANKL Ab 的联合使用加速了骨缺损处的松质骨再生,并比单独使用任何一种药物更有效地增加胫骨的松质骨量,但在皮质骨的再生中没有观察到这些附加作用。